| Bioactivity | Benzoquinoquinoxaline (BQQ) is a heterocyclic compound with an aminoalkyl side chain. Benzoquinoquinoxaline preferentially binds to DNA triplex structures, intercalates between the bases, thus, stabilising the triplex conformation. Conjugation of Benzoquinoquinoxaline to 1,10-phenanthroline specifically binds and cleaves double strand DNA at the site of formation of a triplex structure[1]. | ||||||||||||
| Name | Benzoquinoquinoxaline | ||||||||||||
| CAS | 207671-99-6 | ||||||||||||
| Formula | C23H21N5O | ||||||||||||
| Molar Mass | 383.45 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Umek T, et al. Oligonucleotide Binding to Non-B-DNA in MYC. Molecules. 2019 Mar 12;24(5):1000. |
Benzoquinoquinoxaline
CAS: 207671-99-6 F: C23H21N5O W: 383.45
Benzoquinoquinoxaline (BQQ) is a heterocyclic compound with an aminoalkyl side chain. Benzoquinoquinoxaline preferential
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.